Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis
NCT00438022 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240
Last updated 2016-10-06
Summary
Atopic Dermatitis (AD), also known as eczema, is a skin disease that causes the skin to be hot, dry and scaly, and have severe itching. There are different kinds of eczema. Eczema herpeticum (EH) is a type of eczema that spreads due to an underlying herpes virus infection. The purpose of this research study is to identify the risk factors that may cause EH.
Conditions
- Atopic Dermatitis
- Eczema Herpeticum
Sponsors & Collaborators
-
Atopic Dermatitis and Vaccinia Network
collaborator NETWORK -
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Thomas Bieber, MD, PhD · University of Bonn
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-03-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- Germany
Study Locations
More Related Trials
-
Immune Response to Varicella Vaccination in Children With Atopic Dermatitis
NCT00406081 ·Status: COMPLETED
-
Effects of Treatments on Atopic Dermatitis
NCT01631617 ·Status: RECRUITING ·Phase: PHASE2
-
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
NCT04274348 ·Status: COMPLETED ·Phase: NA
-
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
NCT01782703 ·Status: ACTIVE_NOT_RECRUITING
-
Staphylococcus Aureus in Atopic Dermatitis Immunopathology
NCT04715087 ·Status: COMPLETED ·Phase: NA
-
Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy
NCT02763722 ·Status: UNKNOWN ·Phase: NA
-
Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)
NCT03823794 ·Status: COMPLETED
-
Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum
NCT04060550 ·Status: UNKNOWN
-
Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
NCT05819463 ·Status: RECRUITING
-
Microbiome in Atopic Dermatitis Under Systemic Therapy
NCT05099315 ·Status: RECRUITING
-
Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels
NCT00616096 ·Status: COMPLETED ·Phase: NA
-
Herbal Ointment in Treating Atopic Dermatitis Topically
NCT06850311 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
NCT00605878 ·Status: RECRUITING
-
Scratch and Sleep Quantification in Atopic Dermatitis
NCT03490877 ·Status: COMPLETED
-
Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients
NCT06983561 ·Status: COMPLETED
-
Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis
NCT00723489 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management
NCT01660217 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Effect of Bathing Additives in Atopic Dermatitis
NCT04001855 ·Status: TERMINATED ·Phase: NA
-
The Skin Microbiota in Skin Disease and Eczema
NCT06924333 ·Status: ENROLLING_BY_INVITATION
-
Characterisation of Skin Microstructure Under Normal and Atrophied States
NCT06954272 ·Status: RECRUITING
-
The Factors Affecting Atopic Dermatitis in Children Age 1-3
NCT04218877 ·Status: COMPLETED
-
Management of Pruritus With Xyzal in Atopic Dermatitis
NCT00884325 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
NCT06488742 ·Status: RECRUITING ·Phase: NA
-
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
NCT05790083 ·Status: UNKNOWN ·Phase: NA
-
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
NCT04875169 ·Status: COMPLETED ·Phase: PHASE3